CRYP:AU:AU-BetaShares Crypto Innovators ETF (AUD)

ETF | Others |

Last Closing

USD 6.08

Change

+0.69 (+12.80)%

Market Cap

N/A

Volume

0.82M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
VAS:AU Vanguard Australian Shares

+0.83 (+0.82%)

USD 16.82B
IVV:AU iShares Core S&P 500 AUD

+1.78 (+3.08%)

USD 8.73B
VGS:AU Vanguard MSCI International Sh..

+3.15 (+2.43%)

USD 8.59B
QUAL:AU VanEck Vectors MSCI World ex A..

+2.84 (+5.16%)

USD 6.70B
IOZ:AU Ishares Core S&P/Asx 200

+0.26 (+0.79%)

USD 6.18B
STW:AU SPDR® S&P/ASX 200 Fund

+0.64 (+0.87%)

USD 5.58B
NDQ:AU Betashares Nasdaq 100

+1.38 (+3.06%)

USD 5.22B
HNDQ:AU BetaShares NASDAQ 100 ETF - Cu..

+0.97 (+2.40%)

USD 4.86B
A200:AU BetaShares Australia 200

+1.17 (+0.86%)

USD 4.72B
VTS:AU Vanguard US Total Market Share..

+13.25 (+3.10%)

USD 4.71B

ETFs Containing CRYP:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.84% 84% B 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.84% 84% B 65% D
Trailing 12 Months  
Capital Gain 100.00% 98% N/A 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.00% 98% N/A 77% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 38.20% 100% F 78% C+
Dividend Return 38.20% 100% F 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 52.73% 2% F 39% F
Risk Adjusted Return 72.44% 77% C+ 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.